Charlotte Levin Tykjær Jørgensen

Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial

Anna-Maria Larsson, Sara Jansson, Pär‐Ola Bendahl et al. · Breast Cancer Research · 2018 · 130 citations · Full text

Medicine, Oncology, Breast Oncology +16

Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression

Charlotte Levin Tykjær Jørgensen, Carina Forsare, Pär‐Ola Bendahl et al. · Breast Cancer Research and Treatment · 2020 · 52 citations · Full text

Medicine, Oncology, Pathology +17

PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications

Charlotte Levin Tykjær Jørgensen, Anna-Maria Larsson, Carina Forsare et al. · Cancers · 2021 · 41 citations · Full text

Medicine, Molecular Biology, Oncology +17

Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer

Anna-Maria Larsson, Pär‐Ola Bendahl, Kristina Aaltonen et al. · Scientific Reports · 2020 · 36 citations · Full text

Medicine, Oncology, Pharmacology +15

Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group

Dorte Nielsen, Karsten Bjerre, Erik Jakobsen et al. · Journal of Clinical Oncology · 2011 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17